Speaker Profile

Ph.D., Professor, Stanford

Biography
Dr. Scott is a Professor in the Department of Pathology at Stanford University and Director of the Stanford Medicine Clinical Genomics Laboratory, where he oversees genomic test innovation and implementation. In addition, Dr. Scott is certified by the American Board of Medical Genetics and Genomics (ABMGG) in Clinical Molecular Genetics and Genomics, and Clinical Cytogenetics, and his research interests include human genomics, pharmacogenomics, cytogenomics, long-read sequencing, and the implementation of genomic medicine. He is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), PharmGKB, PharmCAT, PharmVar, AMP Pharmacogenomics Working Group, International Union of Basic and Clinical Pharmacology (IUPHAR), and other national human genomics consortia (ClinGen, UDN, GREGoR). He has co-authored several CPIC practice guidelines and has published over 140 peer-reviewed manuscripts and book chapters on clinical genomics, pharmacogenomics, and genomic medicine implementation.


Talk
Clinical Pharmacogenomic Testing: Sequencing Innovations and Reporting
This presentation will discuss innovative sequencing solutions for clinical pharmacogenomic testing, as well as provide an overview of clinical pharmacogenomic reporting best practices.


 Session Abstract – PMWC 2023 Silicon Valley

Track 1 - January 27 9.00 A.M.-4.15 P.M.


Track Co-Chair:
Mary Relling, St. Jude

Pharmacists have long recognized that using unique patient characteristics to guide pharmacotherapy decision-making can improve drug response and mitigate drug-associated risks. Age, weight, and dietary habits were among the first patient-specific characteristics used to individualize pharmacotherapy. As technologies advanced, analytic tools that measure surrogate markers of liver and renal function, together with drug concentrations in biological fluids, were adopted to optimize therapeutic regimens. Cutting-edge genomic technologies are now being integrated into patient care for the selection of targeted therapies and identification of those at increased risk of poor pharmacotherapy outcomes. We’re excited to bring together experts who are advancing pharmacogenomics at scale through cutting edge clinical implementation, research, and education.

  • PMWC 2023 PGx Award Ceremony:
    Pioneer Honoree: Dan Roden, Vanderbilt University Medical Center
    Luminary Honoree: Kelly E. Caudle, St. Jude
  • Fireside Chat:
    PMWC 2023 Pioneer Honoree Dan Roden, Vanderbilt University Medical Center with Mary Relling, St. Jude
  • Keynote by PMWC 2023 Luminary Honoree:
    - Kelly E. Caudle, St. Jude
  • Fireside Chat:
    Chair: Damon Hostin, Illumina
    - Howard McLeod, Intermountain Health
  • Laboratory Testing and Reports
    Chair: Kristy Crooks, University of Colorado
    - Ann M. Moyer, Mayo Clinic
    - Stuart Scott, Stanford University
  • Implementation of PGx at UCSF
    - Bani Tamraz, UCSF
  • From Economics to Reimbursement (PANEL)
    Chair: Sara Rogers, American Society of Pharmacovigilance
    - Stirling Bryan, The University of British Columbia
    - Ray Stultz, Optum
    - Gabriel Bien-Willner, Palmetto GBA
  • Policy Efforts to Address Barriers to PGx Adoption
    Chair: Kristine Ashcraft, Invitae
    - Pam Traxel, ACS CAN
  • PGx Practice Liability
    Chair: Dan Hertz, University of Michigan
    - Anthony Morreale, VA, San Diego
    - Karen Merritt, Patient Advocate
  • Diversity, Equity, and Inclusion in Pharmacogenomics Implementation
    - Carlos Bustamante, Galatea Bio
    - Kathy Giacomini, UCSF
  • Implementation of PGx Program & PGx Clinic Services in a Large Rural Healthcare Setting
    - April Schultz, Sanford